Immunization

topical fungal infection :: Article Creator Mild To Serious: Stages Of Fungal Infection Fungal infections are a common occurrence that can affect various parts of the body, including the skin, nails, and mucous membranes. In an interaction with Only My Health, Dr S K Gupta, dermatologist at DMCH, Darbhanga, Bihar, explained the different stages of fungal infections is vital for early detection, accurate diagnosis, and prompt treatment.  Initial Infection The first stage of a fungal infection occurs when the fungal organism gains entry into the body. This can happen through direct contact with contaminated surfaces, inhalation of fungal spores, or compromised skin barriers. Initially, the infection may appear as a small red patch, a rash, or localised itching. In some cases, the affected area may be accompanied by slight inflammation or swelling. It is important to identify these early signs and seek medical attention to prevent the infectio

anti inflammatory drugs :: Article Creator FDA Approves Lodoco, First Anti-Inflammatory Drug For Cardiovascular Disease. Here's Why It's A Big Deal The FDA recently approved the first anti-inflammatory drug for cardiovascular disease called LODOCO (colchicine). The recently approved medication has been shown to reduce cardiac event risk in adults with atherosclerotic cardiovascular disease (ASCVD) or with multiple risk factors for cardiovascular disease by an additional 31% compared to standard-of-care treatment. LODOCO can be used alone or in combination with cholesterol-lowering medications. The Food and Drug Administration (FDA) has approved the first-ever anti-inflammatory drug for cardiovascular disease. Called LODOCO (colchicine, 0.5mg), the recently approved medication has been shown to reduce cardiac event risk in adults with atherosclerotic cardiovascular disease (ASCVD) or with multiple risk factors for cardiovascular d

pneumococcal polysaccharide conjugate vaccine :: Article Creator Merck Says 21-valent Pneumococcal Conjugate Vaccine,V116, Meets Key Endpoints In Phase 3 Trials (RTTNews) - Merck & Co., Inc. (MRK) said Thursday that V116, an investigational, 21-valent pneumococcal conjugate vaccine specifically designed for adults, met key immunogenicity and safety endpoints in two phase 3 trials. The topline results demonstrated V116 elicited positive immune responses in both vaccine-naïve and vaccine-experienced adult patient populations, the company said in a statement. The company noted that the results will be shared with the scientific community in the near future and will support global regulatory licensure applications. According to pre-pandemic 2019 CDC data, the 21 serotypes covered by V116 are responsible for 85% of invasive pneumococcal disease in individuals 65 and older. For More Such Health News, visit rttnews.Com SK Bioscience-Sanofi An

preventive health check up list :: Article Creator Health Tests & Screenings Every Woman Should Get Depending on a woman's age and stage of life, certain health screenings and tests are recommended to identify the presence of various medical conditions or early signs that they're developing. While there are general guidelines for which tests to have and when, you may need to get screened sooner or more often than what's generally recommended, depending on your personal and family medical histories. "Coming up with a [universal] proper age for a screening test is really hard because you have to factor in costs and personal risk factors," says Heather Hirsch, M.D., clinical program director of the Menopause & Midlife Clinic at the Brigham and Women's Hospital in Boston. Many of these tests can be performed in your doctor's office while others require a visit to a radiology center. Blood Pressure Test Why it

antidepressants :: Article Creator Woman Denied Police Job Because She Was Taking Antidepressants Launches Legal Action 29 July 2023, 18:20 Laura Mackenzie said she was denied her "dream job" as a probationary officer in the Highlands. Picture: Alamy A woman whose job offer at Police Scotland was withdrawn after she revealed she is taking antidepressants is taking the force to court. Laura Mackenzie said it was her "dream job" to become a probationary officer in Police Scotland's Highlands and Islands division. After sailing through her interview, she was given a date for a medical and a uniform fitting. At the medical Laura was asked about antidepressants - and had the job offer revoked when she said she was taking them. The force has a "two-year rule", with probation officers required to be free of antidepressants for an extended period before they can be considered for employment. Laura sa